Which contact lens fits better? small study compares two toric lenses

NCT ID NCT06431061

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study compared how well two types of toric contact lenses (Proclear Toric and Biofinity Toric) fit in people with astigmatism. Thirty-seven adults who already wear toric lenses tried each lens for 15 minutes. The goal was to see which lens had a better fit. The study is complete and provides information on short-term lens performance.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
contact lenses (omafilcon B and comfilcon A)

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

37 people

The number who actually took part.

Started

Jun 2024

Finished

Nov 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Are at least 17 years of age and has full legal capacity to volunteer. 2. Have understood and signed an information consent letter. 3. Are willing and able to follow instructions and maintain the appointment schedule. 4. Are an adapted soft toric contact lens wearer. 5. Do not habitually wear either of the two study lens types. 6. Have a vertex-corrected contact lens prescription with a spherical component of +4.00D to -9.00D in combination with astigmatism of no less than -0.75D and no more than -2.25D in each eye. 7. Can achieve best corrected distance visual acuity of +0.10 logMAR (subjective refraction) or better in each eye. 8. Can be fitted with and achieve a distance visual acuity of +0.18 logMAR or better in each eye with the study contact lenses. Exclusion Criteria: 1. Are participating in any concurrent clinical or research study. 2. Have any known active ocular disease and/or infection or slit lamp findings that would contraindicate contact lens use. 3. Have a systemic condition that in the opinion of the investigator may affect a study outcome variable. 4. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable. 5. Have known sensitivity to the diagnostic pharmaceuticals to be used in the study. 6. Have a history of not achieving comfortable CL use (5 days per week; \> 8 hours/day) 7. Are an employee of the Centre for Ocular Research \& Education directly involved in the study (i.e. on the delegation log).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Waterloo

    Waterloo, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.